Eagle Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Eagle Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 85% to $316,610,000. The net income raised on $35,642,000 and profit margin reached 11%. Total operating expenses were $140,714,000.
Profit Margin
| 2013 | 13.67M | -6.04M | -44.22% |
|---|---|---|---|
| 2014 | 19.09M | -17.97M | -94.13% |
| 2015 | 66.22M | 2.57M | 3.88% |
| 2016 | 189.48M | 81.45M | 42.99% |
| 2017 | 236.70M | 51.94M | 21.94% |
| 2018 | 213.31M | 31.90M | 14.96% |
| 2019 | 195.89M | 14.31M | 7.31% |
| 2020 | 187.80M | 11.98M | 6.38% |
| 2021 | 171.54M | -8.62M | -5.03% |
| 2022 | 316.61M | 35.64M | 11.26% |
EGRX Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 316.61M | 171.54M | 187.80M | 195.89M | 213.31M | 236.70M | 189.48M | 66.22M | 19.09M | 13.67M |
Cost of revenue | 94.93M | 42.18M | 45.46M | 60.89M | 61.91M | 57.18M | 55.30M | 15.64M | 11.71M | 7.38M |
Gross profit | 221.67M | 129.36M | 142.33M | 134.99M | 151.39M | 179.52M | 134.17M | 50.58M | 7.38M | 6.29M |
Operating exp. | ||||||||||
Research and development | 34.08M | 51.27M | 30.78M | 36.81M | 44.41M | 32.60M | 30.26M | 27.85M | 16.81M | 9.79M |
Selling and marketing | 8.5M | 8.5M | 2.7M | 2.4M | 3.3M | -1.65M | 14.78M | 4.75M | 4.30M | 0 |
Total operating expenses | 140.71M | 126.59M | 109.38M | 113.18M | 104.92M | 104.02M | 82.57M | 48.02M | 26.14M | 14.75M |
Operating income | 53.45M | -2.91M | 25.25M | 21.81M | 36.61M | 73.99M | 53.35M | 2.56M | -18.75M | -8.45M |
Other income (expenses), net | 7.97M | -1.63M | -10.27M | 183K | -9.85M | -1.04M | 1.75M | 14K | -515K | 3.00M |
Income before tax | 61.43M | -4.54M | 22.67M | 21.99M | 34.03M | 72.94M | 53.42M | 2.57M | -19.27M | -6.94M |
Income tax expense | 25.79M | 4.07M | 10.68M | 7.68M | 2.13M | 21.00M | -28.02M | 3K | -1.29M | -898.70K |
Net income | 35.64M | -8.62M | 11.98M | 14.31M | 31.90M | 51.94M | 81.45M | 2.57M | -17.97M | -6.04M |
Earnings per share | ||||||||||
Basic EPS | 2.76 | -0.66 | 0.89 | 1.04 | 2.16 | 3.44 | 5.24 | 0.17 | -1.81 | -0.57 |
Diluted EPS | 2.73 | -0.66 | 0.87 | 1.01 | 2.09 | 3.27 | 4.96 | 0.16 | -1.81 | -0.57 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |